About Psychemedics Corporation (NASDAQ:PMD)
Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company's primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company's tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical & Diagnostic Laboratories
- Sub-Industry: N/A
- Symbol: NASDAQ:PMD
- CUSIP: N/A
- Web: www.psychemedics.com
- Market Cap: $91.96 million
- Outstanding Shares: 5,491,000
- 50 Day Moving Avg: $18.42
- 200 Day Moving Avg: $21.11
- 52 Week Range: $13.81 - $27.99
Sales & Book Value:
- Trailing P/E Ratio: 12.3582
- P/E Growth: 0.0000
- Annual Revenue: $42.51 million
- Price / Sales: 2.15
- Book Value: $2.99 per share
- Price / Book: 5.57
- Annual Dividend: $0.60
- Dividend Yield: 3.6%
- EBITDA: $13.84 million
- Net Margins: 17.59%
- Return on Equity: 47.94%
- Return on Assets: 29.82%
- Debt-to-Equity Ratio: 0.06%
- Current Ratio: 3.00%
- Quick Ratio: 3.00%
- Average Volume: 40,548 shs.
- Beta: 1
- Short Ratio: 0.91
Frequently Asked Questions for Psychemedics Corporation (NASDAQ:PMD)
What is Psychemedics Corporation's stock symbol?
Psychemedics Corporation trades on the NASDAQ under the ticker symbol "PMD."
How often does Psychemedics Corporation pay dividends? What is the dividend yield for Psychemedics Corporation?
Psychemedics Corporation declared a quarterly dividend on Thursday, August 3rd. Investors of record on Monday, August 14th will be paid a dividend of $0.15 per share on Thursday, August 24th. This represents a $0.60 dividend on an annualized basis and a yield of 3.60%. The ex-dividend date of this dividend is Thursday, August 10th. View Psychemedics Corporation's Dividend History.
How were Psychemedics Corporation's earnings last quarter?
Psychemedics Corporation (NASDAQ:PMD) announced its earnings results on Wednesday, August, 2nd. The company reported $0.16 EPS for the quarter. The business earned $9.68 million during the quarter. Psychemedics Corporation had a net margin of 17.59% and a return on equity of 47.94%. View Psychemedics Corporation's Earnings History.
When will Psychemedics Corporation make its next earnings announcement?
Who are some of Psychemedics Corporation's key competitors?
Some companies that are related to Psychemedics Corporation include Kamada (KMDA), OVID THERAPEUTC (OVID), Quotient Limited (QTNT), Cogentix Medical (CGNT), Fate Therapeutics (FATE), Pluristem Therapeutics (PSTI), Recro Pharma (REPH), Organovo Holdings (ONVO), Agile Therapeutics (AGRX), Osiris Therapeutics (OSIR), Cytosorbents Corporation (CTSO), XOMA Corporation (XOMA), Merrimack Pharmaceuticals (MACK), Marinus Pharmaceuticals (MRNS), Adamis Pharmaceuticals Corporation (ADMP), Vascular Biogenics (VBLT), BioDelivery Sciences International (BDSI) and Concord Medical Services Holdings Limited (CCM).
Who are Psychemedics Corporation's key executives?
Psychemedics Corporation's management team includes the folowing people:
- Raymond C. Kubacki Jr., Chairman of the Board, President, Chief Executive Officer
- Neil L. Lerner, Vice President - Finance
- Michael I. Schaffer Ph.D., Vice President - Laboratory Operations
- A. Clinton Allen, Independent Director
- Harry F. Connick Sr., Independent Director
- Walter S. Tomenson Jr., Independent Director
- Fred J. Weinert, Independent Director
How do I buy Psychemedics Corporation stock?
Shares of Psychemedics Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Psychemedics Corporation's stock price today?
MarketBeat Community Rating for Psychemedics Corporation (NASDAQ PMD)MarketBeat's community ratings are surveys of what our community members think about Psychemedics Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Psychemedics Corporation stock can currently be purchased for approximately $16.65.
Consensus Ratings for Psychemedics Corporation (NASDAQ:PMD) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for Psychemedics Corporation (NASDAQ:PMD)
Analysts' Ratings History for Psychemedics Corporation (NASDAQ:PMD)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Psychemedics Corporation (NASDAQ:PMD)Earnings History by Quarter for Psychemedics Corporation (NASDAQ PMD)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/2/2017||Q2 2017||$0.16||$9.68 million||View||N/A|
|4/25/2017||Q1 2017||$0.27||$10.21 million||View||N/A|
|4/29/2014||Q114||$0.12||$0.14||$6.40 million||$7.00 million||View||N/A|
|2/25/2013||Q4 2012||$0.05||$5.55 million||$5.66 million||View||N/A|
Earnings Estimates for Psychemedics Corporation (NASDAQ:PMD)
No earnings estimates for this company have been tracked by MarketBeat.com
Current Dividend Information for Psychemedics Corporation (NASDAQ:PMD)
|Most Recent Dividend:||8/24/2017|
|Payout Ratio:||44.44% (Trailing 12 Months of Earnings) |
Dividend History by Quarter for Psychemedics Corporation (NASDAQ PMD)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Psychemedics Corporation (NASDAQ:PMD)
Insider Ownership Percentage: 8.60%Insider Trades by Quarter for Psychemedics Corporation (NASDAQ:PMD)
Institutional Ownership Percentage: 58.18%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/6/2017||Michael I Schaffer||VP||Sell||7,548||$20.41||$154,054.68|| |
|9/5/2017||Michael I Schaffer||VP||Sell||4,400||$20.37||$89,628.00|| |
|9/1/2017||Michael I Schaffer||VP||Sell||981||$21.16||$20,757.96|| |
|3/9/2017||James V Dyke||VP||Sell||10,513||$20.56||$216,147.28|| |
|12/14/2016||James V Dyke||VP||Sell||5,091||$22.83||$116,227.53|| |
|12/9/2016||Fred J Weinert||Director||Sell||4,601||$24.45||$112,494.45|| |
|11/18/2016||Neil Lerner||VP||Sell||3,000||$24.75||$74,250.00|| |
|11/15/2016||James V Dyke||VP||Sell||10,000||$23.56||$235,600.00|| |
|3/2/2016||Harry F Sr Connick Sr||Director||Buy||700||$12.83||$8,981.00|| |
|2/26/2016||Harry F Sr Connick Sr||Director||Buy||1,000||$12.63||$12,630.00|| |
|2/24/2016||Harry F Sr Connick Sr||Director||Buy||2,000||$12.36||$24,720.00|| |
|2/22/2016||Harry F Sr Connick Sr||Director||Buy||1,000||$12.61||$12,610.00|| |
|2/19/2016||Harry F Sr Connick Sr||Director||Buy||1,000||$11.95||$11,950.00|| |
|2/16/2016||Michael I Schaffer||VP||Buy||4,507||$11.09||$49,982.63|| |
|9/14/2015||Raymond C. Kubacki, Jr.||CEO||Buy||2,000||$10.12||$20,240.00|| |
|9/10/2015||Neil Lerner||VP||Buy||3,000||$10.32||$30,960.00|| |
|6/16/2015||Michael I Schaffer||VP||Sell||2,837||$14.62||$41,476.94|| |
Headline Trends for Psychemedics Corporation (NASDAQ:PMD)
Latest Headlines for Psychemedics Corporation (NASDAQ:PMD)
Loading headlines, please wait.
Psychemedics Corporation (PMD) Chart for Tuesday, October, 24, 2017